Literature DB >> 25595807

The cytoplasmic tail of retroviral envelope glycoproteins.

Philip R Tedbury1, Eric O Freed2.   

Abstract

Retroviruses comprise a large, diverse group that infects a broad range of host organisms. Pathogenicity varies widely; the human immunodeficiency virus is the causative agent of acquired immunodeficiency syndrome, one of the world's leading infectious causes of death, while many nonhuman retroviruses cause cancer in the host. Retroviruses have been studied intensively, and great strides have been made in understanding aspects of retroviral biology. While the principal functions of the viral structural proteins are well understood, there remain many incompletely characterized domains. One of these is the cytoplasmic tail (CT) of the envelope glycoprotein. Several functions of the CT are highly conserved, whereas other properties are unique to a specific retrovirus. For example, the lentiviruses encode envelope glycoproteins with particularly large cytoplasmic domains. The functions of the long lentiviral envelope CT are still being deciphered. The reported functions of retroviral envelope CTs are discussed in this chapter.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytoplasmic tail; Envelope; HIV; Lentivirus; MLV; Membrane fusion; Retrovirus; Signaling; Trafficking; Virus assembly

Mesh:

Substances:

Year:  2014        PMID: 25595807      PMCID: PMC6941201          DOI: 10.1016/bs.pmbts.2014.10.009

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  193 in total

1.  Budding capability of the influenza virus neuraminidase can be modulated by tetherin.

Authors:  Mark A Yondola; Fiona Fernandes; Alan Belicha-Villanueva; Melissa Uccelini; Qinshan Gao; Carol Carter; Peter Palese
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

2.  Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance.

Authors:  S Alireza Rabi; Gregory M Laird; Christine M Durand; Sarah Laskey; Liang Shan; Justin R Bailey; Stanley Chioma; Richard D Moore; Robert F Siliciano
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808

3.  Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions.

Authors:  L G Perez; G L Davis; E Hunter
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.

Authors:  James H Morrison; Rebekah B Guevara; Adriana C Marcano; Dyana T Saenz; Hind J Fadel; Daniel K Rogstad; Eric M Poeschla
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

5.  Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.

Authors:  C C LaBranche; T L Hoffman; J Romano; B S Haggarty; T G Edwards; T J Matthews; R W Doms; J A Hoxie
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells.

Authors:  A Kikonyogo; F Bouamr; M L Vana; Y Xiang; A Aiyar; C Carter; J Leis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

7.  The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques.

Authors:  B L Shacklett; C J Weber; K E Shaw; E M Keddie; M B Gardner; P Sonigo; P A Luciw
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

9.  Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex.

Authors:  Mingli Qi; Janice A Williams; Hin Chu; Xuemin Chen; Jaang-Jiun Wang; Lingmei Ding; Ehiole Akhirome; Xiaoyun Wen; Lynne A Lapierre; James R Goldenring; Paul Spearman
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

10.  HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2.

Authors:  Tram N Q Pham; Sabelo Lukhele; Fadi Hajjar; Jean-Pierre Routy; Éric A Cohen
Journal:  Retrovirology       Date:  2014-02-06       Impact factor: 4.602

View more
  11 in total

1.  Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.

Authors:  Yul Eum Song; Grace Y Olinger; Sanath Kumar Janaka; Marc C Johnson
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

2.  Truncating the gp41 Cytoplasmic Tail of Simian Immunodeficiency Virus Decreases Sensitivity to Neutralizing Antibodies without Increasing the Envelope Content of Virions.

Authors:  Ellen White; Fan Wu; Elena Chertova; Julian Bess; James D Roser; Jeffrey D Lifson; Vanessa M Hirsch
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

3.  Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.

Authors:  Philip R Tedbury; Mariia Novikova; Sherimay D Ablan; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

4.  Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail.

Authors:  Melissa V Fernandez; Huxley K Hoffman; Nairi Pezeshkian; Philip R Tedbury; Schuyler B van Engelenburg; Eric O Freed
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

5.  Interaction Interface of Mason-Pfizer Monkey Virus Matrix and Envelope Proteins.

Authors:  Jan Prchal; Jakub Sýs; Petra Junková; Jan Lipov; Tomáš Ruml
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

Review 6.  The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.

Authors:  R Elliot Murphy; Jamil S Saad
Journal:  Viruses       Date:  2020-05-16       Impact factor: 5.048

Review 7.  Revisiting Membrane Microdomains and Phase Separation: A Viral Perspective.

Authors:  Prabuddha Sengupta; Jennifer Lippincott-Schwartz
Journal:  Viruses       Date:  2020-07-10       Impact factor: 5.048

8.  Elucidating the Antiviral Mechanism of Different MARCH Factors.

Authors:  Supawadee Umthong; Brian Lynch; Uddhav Timilsina; Brandon Waxman; Emily B Ivey; Spyridon Stavrou
Journal:  mBio       Date:  2021-03-02       Impact factor: 7.867

9.  Mason-Pfizer Monkey Virus Envelope Glycoprotein Cycling and Its Vesicular Co-Transport with Immature Particles.

Authors:  Petra Grznárová Prokšová; Jan Lipov; Jaroslav Zelenka; Eric Hunter; Hana Langerová; Michaela Rumlová; Tomáš Ruml
Journal:  Viruses       Date:  2018-10-20       Impact factor: 5.048

10.  A novel class III endogenous retrovirus with a class I envelope gene in African frogs with an intact genome and developmentally regulated transcripts in Xenopus tropicalis.

Authors:  Venkat R K Yedavalli; Akash Patil; Janay Parrish; Christine A Kozak
Journal:  Retrovirology       Date:  2021-07-14       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.